Global Congestive Heart Failure (CHF) Treatment Devices Market to Reach $37.9 Billion by 2030
The global market for Congestive Heart Failure (CHF) Treatment Devices estimated at US$22.2 Billion in the year 2022, is projected to reach a revised size of US$37.9 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$15.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pacemakers segment is readjusted to a revised 6.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $6.1 Billion, While China is Forecast to Grow at 12.1% CAGR
The Congestive Heart Failure (CHF) Treatment Devices market in the U.S. is estimated at US$6.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$9.3 Billion by the year 2030 trailing a CAGR of 12.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 5.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.Select Competitors (Total 33 Featured) -
- Berlin Heart GmbH
- Biotronik SE & Co., KG
- Boston Scientific Corporation
- Jarvik Heart Inc.
- Medtronic
- ReliantHeart, Inc.
- St. Jude Medical, Inc.
- Teleflex, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Congestive Heart Failure (CHF) Treatment Devices - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for ImplanTable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for ImplanTable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for ImplanTable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Cardiac Resynchronization therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Cardiac Resynchronization therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Cardiac Resynchronization therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 16: World Congestive Heart Failure (CHF) Treatment Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 17: USA Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 18: USA Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 19: USA 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
CANADA
- Table 20: Canada Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 21: Canada Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 22: Canada 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
JAPAN
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 23: Japan Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 24: Japan Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 25: Japan 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
CHINA
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 26: China Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: China Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 28: China 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
EUROPE
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 29: Europe Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 30: Europe Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 31: Europe 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 32: Europe Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Europe Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 34: Europe 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
FRANCE
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 35: France Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: France Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 37: France 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
GERMANY
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 38: Germany Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Germany Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 40: Germany 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
ITALY
- Table 41: Italy Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Italy Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 43: Italy 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 44: UK Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: UK Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 46: UK 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
SPAIN
- Table 47: Spain Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: Spain Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 49: Spain 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
RUSSIA
- Table 50: Russia Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Russia Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 52: Russia 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 53: Rest of Europe Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Rest of Europe Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 55: Rest of Europe 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 57: Asia-Pacific Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 58: Asia-Pacific 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: Asia-Pacific Historic Review for Congestive Heart Failure (CHF) Treatment Devices by Product - ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 61: Asia-Pacific 16-Year Perspective for Congestive Heart Failure (CHF) Treatment Devices by Product - Percentage Breakdown of Value Sales for ImplanTable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy and Other Products for the Years 2014, 2023 & 2030
AUSTRALIA
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
LATIN AMERICA
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
MIDDLE EAST
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
AFRICA
- Congestive Heart Failure (CHF) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Berlin Heart GmbH
- Biotronik SE & Co., KG
- Boston Scientific Corporation
- Jarvik Heart Inc.
- Medtronic
- ReliantHeart, Inc.
- St. Jude Medical, Inc.
- Teleflex, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 22.2 Billion |
Forecasted Market Value ( USD | $ 37.9 Billion |
Compound Annual Growth Rate | 6.9% |
Regions Covered | Global |